Amgen (AMGN.Q) signed a lease with BioMed Realty for a new 240,000 square foot Leadership in Energy and Environmental Design (LEED) candidate facility in the Gateway of Pacific campus development in south San Francisco earlier this week.
50 years I’ve been bumbling around this planet, and the best damn weekend I’ve had on it to date occurred recently, under the influence of mushrooms.
December 9, 2019 – “Merger Monday” – a couple of Big Pharma companies announced plans to acquire two cancer-focused biotechs – in separate deals worth a combined $5.2 billion.
Oracle (ORCL.NYSE) leverages artificial intelligence to connect cancer patients with clinical trials
Oracle Health Sciences, the medical sciences wing of Oracle (ORCL.NYSE), is participating in The Opportunity Project (TOP) Technology Spring: Creating the Future of Health.
WELL Health Technologies (WELL.V) has acquired 51% in Burnaby, BC based integrated medical services provider, Spring Medical.
Ever since the greasy arrogant squirrel-faced grin of Martin Shkreli turned our collective stomach, big pharma has come under fire for their pricing practices. Pharma execs, often paid up to 300 times more than their average employee, shot back that research and development costs were crippling and all that needed to be paid for with healthy profit margins. Should we just buck up and shut up, or are we witnessing the brain death of big pharma?
When markets closed Friday November 15, Karuna Therapeutics (KRTX.Q) was just another pharma-stock trading in the mid-teens trying to make drugs for patients with Alzheimer’s and Schizophrenia.
Varian Medical Systems (VAR.NYSE) announced that the South Florida Proton Therapy Institute (SFPTI) has treated its first patient using the Varian ProBeam Compact single-room proton therapy system.
Cognetivity Neurosciences (CGN.C) has reached the threshold of participants in their clinical evaluation study of its integrated cognitive assessment (ICA) platform for dementia sufferers to register for CE marking.
Johnson & Johnson (JNJ.NYSE) issued a recall for a single lot of its Baby Powder in response to a FDA test that uncovered the presence of sub-trace levels (no greater than 0.00002%) of chrysotile asbestos contamination in samples from a single bottle purchased from an online retailer.
Australia is a member of the assorted collection of countries with aging populations and an extreme shortage of doctor’s and nurses.
Beyond Boobs: Else Nutrition (BABY.V) is the plant-based baby formula alternative, and it’s a big deal
The scene: Late 2005, a run down pharmacy in East Vancouver. It’s early on a Sunday morning, raining heavily outside, and I haven’t slept for three days other than in half hour spurts, usually on the couch, or even on the floor.